COMBINAÇÃO DE TERAPIAS COMPREENDENDO INIBIDORES P13K-ALPHA À BASE DE QUINOXALINA PARA USO NO TRATAMENTO DO CÂNCER.

摘要

The present invention provides methods of treating cancer by administering a compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with other cancer treatments.